DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

H.C. Wainwright Reiterates Buy on Zymeworks, Lowers Price Target to $60

H.C. Wainwright analyst Debjit Chattopadhyay reiterates Zymeworks (NYSE:ZYME) with a Buy and lowers the price target from $65 to $60.

Benzinga · 03/03/2020 18:14

H.C. Wainwright analyst Debjit Chattopadhyay reiterates Zymeworks (NYSE:ZYME) with a Buy and lowers the price target from $65 to $60.